ArticlePatient preference and adherence2022
Validation of the Chinese Version Community's Self-Efficacy Scale in Community-Dwelling Older Adults.
Article in Patient preference and adherence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 citations in OpenAlex.
- The influence of group Tai Chi practice on loneliness among older adults living alone in Wuhan: the mediating role of social self-efficacy.BMC psychology · 2026Trial
- Illness acceptance and community self-efficacy mediate the relationship between social isolation and loneliness among elderly people with parkinson's disease.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The original study confirmed that the Japanese version of the community's self-efficacy scale (CSES) may help to promote health policies, practices and interventions in the community. In China, research on the self-efficacy of community's life is in its infancy. The aim of this study was to assess the validity, the reliability and the predictors of the Chinese version CSES in the aging population. Methods: (1) Translation of the original Japanese version CSES into Chinese; (2) validation of the Chinese version in the aging population. Instrument measurement included reliability testing, item generation, construct validity and test-retest reliability. Confirmatory factor analysis was applied to determine construct validity and internal consistency. Meanwhile, we built the Bayesian network model of the Chinese version of CSES and determined target variables. Results: Finally, 143 sample individuals have been included in this research. By confirmatory factor analysis, we confirmed that the Chinese version CSES fits a two-dimensional model. Additionally, this scale showed good internal consistency (Cronbach's α coefficient 0.900) and test-retest reliability (kappa coefficient 0.754). The results of the Bayesian network model showed that the education (0.3278) and the perceived efficacy patient-physician interactions scale (0.2055) are important predictors of the CSES. Conclusion: This is the first study to validate the Chinese version of CSES in older people. Our research confirmed that the Chinese version CSES has good internal consistency, construct validity and test-retest reliability. Meanwhile, patient's confidence in communication with a physician and the patient's educational level were the important predictors of community self-efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.